Mutant KRAS proteins with defective GTPase activity remain locked in the “ON” state, persistently activating downstream signaling and driving uncontrolled cell proliferation, a hallmark of CRC [42,45]. The gene discussed is KRAS; the disease is colorectal carcinoma.